Corbenic Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-58
| Closed | -$14K | – | 259 |
|
|
2020
Q4 | $14K | Hold |
58
| – | – | 0.01% | 114 |
|
|
2020
Q3 | $16K | Sell |
58
-11
| -16% | -$3.03K | 0.01% | 96 |
|
|
2020
Q2 | $20K | Hold |
69
| – | – | 0.01% | 86 |
|
|
2020
Q1 | $16K | Hold |
69
| – | – | 0.01% | 89 |
|
|
2019
Q4 | $15K | Buy |
+69
| New | +$15K | 0.01% | 111 |
|
|
2017
Q4 | – | Sell |
-78
| Closed | -$12K | – | 248 |
|
|
2017
Q3 | $12K | Buy |
+78
| New | +$12K | 0.02% | 138 |
|
|
2017
Q1 | – | Sell |
-24
| Closed | -$2K | – | 218 |
|
|
2016
Q4 | $2K | Hold |
24
| – | – | ﹤0.01% | 185 |
|
|
2016
Q3 | $2K | Buy |
+24
| New | +$2K | ﹤0.01% | 183 |
|
|
2015
Q1 | – | Sell |
-38
| Closed | -$5K | – | 216 |
|
|
2014
Q4 | $5K | Buy |
+38
| New | +$5K | ﹤0.01% | 163 |
|